Global COVID-19 Diagnostic Testing Market - Analysis by Test Type (Molecular, Serology), End-User, by Region, by Country (2020 Edition): Market Insights, Competition and Forecast (2020-2025)

Description Table of
Contents Samples Companies Mentioned Methodology

FEATURED COMPANIES

Abbott Laboratories
Becton Dickinson
BGI Genomics
Biomerieux
Cepheid
PerkinElmer
MORE

Executive Summary

The Global COVID-19 Diagnostic Testing Market is estimated to be valued at USD 44481.8 million for the year 2020 owing to a rapid increase in the number of coronavirus cases across the globe which boosts the demand for COVID-19 diagnostic tests. The COVID-19 diagnostic tests are critical in the management of the current pandemic for accurate diagnosis as well as to tackle the spread of the infection. Also, Global COVID-19 Diagnostic Testing market in terms of COVID-19 Tests is expected to reach the number of 329.17 million in the year 2020.

In March 2020, the Food and Drug Administration (FDA) gave Emergency Use Authorization (EUA) to the first POC test-Xpert Xpress test made by Cepheid-for COVID-19 analysis. Abbott and Chembio Diagnostics are among the dynamic market players working for the purpose of care commercial center. The WHO has encouraged healthcare organizations to focus on COVID-19 indicative testing in light of this emergency.

The companies are also adopting profitable strategic moves to gain a competitive edge in the market. For example, in May 2020, Quest Diagnostics announced its collaboration with Ortho Clinical Diagnostics aimed at the expansion of COVID-19 antibody testing across more than 20 laboratories of Quest throughout U.S. The company applied VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test of Ortho to ramp up the coronavirus testing in patients.

Among the Test Type segment in the COVID-19 Diagnostic Testing market (Molecular Tests, Serology Tests), Molecular Test type segment has been gaining popularity among other segments. Robust funding and speculations by public as well as private organizations are relied upon to impel molecular diagnostic organizations to create COVID-19 symptomatic products, in this way driving the market. Based on End-User segment, Private or Commercial labs segment holds the major share in the COVID-19 diagnostic testing market followed by Public health labs and hospitals. Due to the growing number of COVID-19 cases across the globe, it has become imperative for the government of the various countries to involve a greater number of private or commercial firms in providing diagnostic testing in order to enhance the testing capacity to detect the virus.

Scope of the Report

The report analyses the COVID-19 Diagnostic Testing market by Value and by COVID-19 Tests.
The report analyses the COVID-19 Diagnostic Testing Market by Test Type (Molecular Tests, Serology Tests).
The report assesses the COVID-19 Diagnostic Testing market by End-User (Public Health Labs, Private or Commercial Labs, Others).
The Global COVID-19 Diagnostic Testing Market has been analysed by Region (Americas, Europe, Asia Pacific) and by Country (United States, Canada, Brazil, Germany, France, Italy, United Kingdom, Spain, Russia, China, Japan, India, South Korea, Singapore)
The major trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, COVID-19 vaccine development. The companies analysed in the report include Biomerieux, Roche Holding AG, Siemens Healthineers, Abbott Laboratories, Becton Dickinson, Thermo Fisher Scientific, Cepheid, BGI Genomics, Seegene, PerkinElmer.
The report presents the analysis of COVID-19 Diagnostic Testing market for the forecast period of 2020-2025.

Key Target Audience

COVID-19 Diagnostic Test Kit manufacturers, dealers, and suppliers
Pharmaceutical companies
Global Healthcare Agencies
Consulting and Advisory Firms
Government and Policy Makers
Investment Banks and Equity Firms
Regulatory Authorities

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Abbott Laboratories
Becton Dickinson
BGI Genomics
Biomerieux
Cepheid
PerkinElmer
MORE

1. Report Scope and Methodology

1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations3. Global COVID-19 Diagnostic Testing Market: Product Outlook

4. Global COVID-19 Diagnostic Testing Market: Sizing and Forecast

4.1 Market Size, by Value, Year 2020-2025
4.2 Market Size, by COVID-19 Tests, Year 2020-2025

5. Global COVID-19 Diagnostic Testing Market Segmentation by Test Type

5.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: by Test Type
5.2 Molecular Tests-Market Size and Forecast (2020-2025)
5.3 Serology Tests-Market Size and Forecast (2020-2025)

6. Global COVID-19 Diagnostic Testing Market Segmentation by End-User

6.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: by End-User
6.2 Public Health Labs-Market Size and Forecast (2020-2025)
6.3 Private or Commercial Labs-Market Size and Forecast (2020-2025)
6.4 Others-Market Size and Forecast (2020-2025)

7. Global COVID-19 Diagnostic Testing Market: Regional Analysis

7.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: by Region, by Value

8. Americas COVID-19 Diagnostic Testing Market: Segmentation by Test Type, End-User (2020-2025)

8.1 Americas COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
8.2 Americas COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
8.3 Americas COVID-19 Diagnostic Testing Market-Prominent Companies
8.4 Market Segmentation by Test Type (Molecular Tests, Serology Tests)
8.5 Market Segmentation by End-User (Public Health Labs, Private or Commercial Labs, Others)
8.6 Americas COVID-19 Diagnostic Testing Market: Country Analysis
8.7 Competitive Scenario of Americas COVID-19 Diagnostic Testing: by Country, by Value
8.8 United States COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
8.9 United States COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
8.10 United States COVID-19 Diagnostic Testing Market: Prominent Players
8.11 United States COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
8.12 Canada COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
8.13 Canada COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
8.14 Canada COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
8.15 Brazil COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
8.16 Brazil COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
8.17 Brazil COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User

9. Europe COVID-19 Diagnostic Testing Market: Segmentation by Test Type, End-User (2020-2025)

9.1 Europe COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.2 Europe COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.3 Europe COVID-19 Diagnostic Testing Market-Prominent Companies
9.4 Market Segmentation by Test Type (Molecular Tests, Serology Tests)
9.5 Market Segmentation by End-User (Public Health Labs, Private or Commercial Labs, Others)
9.6 Europe COVID-19 Diagnostic Testing Market: Country Analysis
9.7 Competitive Scenario of Europe COVID-19 Diagnostic Testing: by Country, by Value
9.8 Germany COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.9 Germany COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.10 Germany COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
9.11 France COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.12 France COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.13 France COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
9.14 United Kingdom COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.15 United Kingdom COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.16 United Kingdom COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
9.17 Spain COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.18 Spain COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.19 Spain COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
9.20 Italy COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.21 Italy COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.22 Italy COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
9.23 Russia COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
9.24 Russia COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
9.25 Russia COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User

10. Asia Pacific COVID-19 Diagnostic Testing Market: Segmentation by Test Type, End-User (2020-2025)

10.1 Asia Pacific COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
10.2 Asia Pacific COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
10.3 Asia Pacific COVID-19 Diagnostic Testing Market-Prominent Companies
10.4 Market Segmentation by Test Type (Molecular Tests, Serology Tests)
10.5 Market Segmentation by End-User (Public Health Labs, Private or Commercial Labs, Others)
10.6 Asia Pacific COVID-19 Diagnostic Testing Market: Country Analysis
10.7 Competitive Scenario of Asia Pacific COVID-19 Diagnostic Testing: by Country, by Value
10.8 China COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
10.9 China COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
10.10 China COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
10.11 Japan COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
10.12 Japan COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
10.13 Japan COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
10.14 India COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
10.15 India COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
10.16 India COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
10.17 South Korea COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
10.18 South Korea COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
10.19 South Korea COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User
10.20 Singapore COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by Value
10.21 Singapore COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), by COVID-19 Tests
10.22 Singapore COVID-19 Diagnostic Testing Market Segmentation by Test Type, End-User

11. Global COVID-19 Diagnostic Testing Market Dynamics

11.1 Global COVID-19 Diagnostic Testing Market Drivers
11.2 Global COVID-19 Diagnostic Testing Market Restraints
11.3 Global COVID-19 Diagnostic Testing Market Trends

12. COVID-19 Vaccine Development

12.1 Overview of Vaccine Development
12.2 Overview of the leading vaccine candidates

13. Competitive Landscape

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)

14.1 Biomerieux
14.2 Roche Holding AG
14.3 Siemens Healthineers
14.4 Abbott Laboratories
14.5 Becton Dickinson
14.6 Thermo Fisher Scientific
14.7 Cepheid
14.8 BGI Genomics
14.9 Seegene
14.10 PerkinElmer

List of Figures

Figure 1: Global COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 2: Global COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 3: Global Distribution of COVID-19 Cases, by Country (%), Updated upto 12th May, 2020
Figure 4: Total COVID-19 Tests per thousand people, May 12, 2020
Figure 5: Share of COVID-19 Tests that were positive, May 12, 2020
Figure 6: Total Confirmed COVID-19 deaths per million people, May 12, 2020
Figure 7: Percentage of Population Aged 65 or over, 2020
Figure 8: Global COVID-19 Data, Last Updated to 20th May, 2020
Figure 9: Global Population Projection (in Billion), 2020-2040
Figure 10: Countries with highest share of pop aged 65+, 2020
Figure 11: Countries with the most critical care beds per capita
Figure 12: COVID-19 Testing Policies, May 20,2020
Figure 13: Global COVID-19 Diagnostic Testing Market Share-by Test Type, Year 2020 & 2025
Figure 14: Global COVID-19 Diagnostic Testing Market-by Molecular Test, by Value (USD Million), 2020-2025
Figure 15: Global COVID-19 Diagnostic Testing Market-by Serology Test, by Value (USD Million), 2020-2025
Figure 16: Global COVID-19 Diagnostic Testing Market Share-by End-User, Year 2020 & 2025
Figure 17: Global COVID-19 Diagnostic Testing Market-by Public Health Labs, by Value (USD Million), 2020-2025
Figure 18: Global COVID-19 Diagnostic Testing Market-by Private or Commercial Labs, by Value (USD Million), 2020-2025
Figure 19: Global COVID-19 Diagnostic Testing Market-by Others, by Value (USD Million), 2020-2025
Figure 20: Global COVID-19 Diagnostic Testing Market Share-by Region, by Value, Year 2020 & 2025
Figure 21: Americas COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 22: Americas COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 23: North America Total COVID-19 Tests per thousand people, May 18, 2020
Figure 24: South America Total COVID-19 Tests per thousand people, May 18, 2020
Figure 25: North America COVID-19 Testing Policies, May 20,2020
Figure 26: South America COVID-19 Testing Policies, May 20,2020
Figure 27: Americas COVID-19 Data, Last Updated to 21st May, 2020
Figure 28: Americas Population Projection (in Million), 2020-2035
Figure 29: Americas COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 30: Americas COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 31: Americas COVID-19 Diagnostic Testing Market Share-by Country, by Value, Year 2020 & 2025
Figure 32: United States COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 33: United States COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 34: United States COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 35: United States COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 36: Millions of People Aged 65 years or above
Figure 37: United States Population Projection (in Million), 2020-2035
Figure 38: United States COVID-19 Data, Last Updated to 21st May, 2020
Figure 39: Canada COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 40: Canada COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 41: Canada COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 42: Canada COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 43: Canada Population Projection (in Million), 2020-2035
Figure 44: Canada COVID-19 Data, Last Updated to 21st May, 2020
Figure 45: Brazil COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 46: Brazil COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 47: Brazil COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 48: Brazil COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 49: Brazil Population Projection (in Million), 2020-2035
Figure 50: Brazil COVID-19 Data, Last Updated to 21st May, 2020
Figure 51: Europe COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 52: Europe COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 53: Europe Total COVID-19 Tests per thousand people, May 18, 2020
Figure 54: Europe COVID-19 Testing Policies, May 20,2020
Figure 55: Europe COVID-19 Data, Last Updated to 22nd May, 2020
Figure 56: Europe Population Projection (in Million), 2020-2035
Figure 57: Europe COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 58: Europe COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 59: Europe COVID-19 Diagnostic Testing Market Share-by Country, by Value, Year 2020 & 2025
Figure 60: Germany COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 61: Germany COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 62: Germany COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 63: Germany COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 64: Germany Population Projection (in Million), 2020-2035
Figure 65: Germany COVID-19 Data, Last Updated to 21st May, 2020
Figure 66: France COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 67: France COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 68: France COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 69: France COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 70: France Population Projection (in Million), 2020-2035
Figure 71: France COVID-19 Data, Last Updated to 21st May, 2020
Figure 72: United Kingdom COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 73: United Kingdom COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 74: United Kingdom COVID-19 regional test sites
Figure 75: United Kingdom COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 76: United Kingdom COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 77: United Kingdom Population Projection (in Million), 2020-2035
Figure 78: United Kingdom COVID-19 Data, Last Updated to 21st May, 2020
Figure 79: Spain COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 80: Spain COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 81: Spain COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 82: Spain COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 83: Spain Population Projection (in Million), 2020-2035
Figure 84: Spain COVID-19 Data, Last Updated to 21st May, 2020
Figure 85: Italy COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 86: Italy COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 87: Italy COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 88: Italy COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 89: Italy Population Projection (in Million), 2020-2035
Figure 90: Italy Total number of ICU beds, 2015-2020
Figure 91: Italy COVID-19 Data, Last Updated to 21st May, 2020
Figure 92: Russia COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 93: Russia COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 94: Russia COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 95: Russia COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 96: Russia Population Projection (in Million), 2020-2035
Figure 97: Russia COVID-19 Data, Last Updated to 21st May, 2020
Figure 98: Regions with highest coronavirus test conducted in Russia as of 20th May, 2020
Figure 99: Asia Pacific COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 100: Asia Pacific COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 101: Asia Pacific Total COVID-19 Tests per thousand people, May 18, 2020
Figure 102: Asia Pacific COVID-19 Testing Policies, May 20,2020
Figure 103: Asia COVID-19 Data, Last Updated to 24th May, 2020
Figure 104: Asia Population Projection (in Million), 2020-2035
Figure 105: Asia Pacific COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 106: Asia Pacific COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 107: Asia Pacific COVID-19 Diagnostic Testing Market Share-by Country, by Value, Year 2020 & 2025
Figure 108: China COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 109: China COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 110: Coronavirus Testing in China
Figure 111: China COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 112: China COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 113: China Population Projection (in Million), 2020-2035
Figure 114: China COVID-19 Data, Last Updated to 21st May, 2020
Figure 115: Japan COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 116: Japan COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 117: Japan COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 118: Japan COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 119: Japan Population Projection (in Million), 2020-2035
Figure 120: Japan COVID-19 Data, Last Updated to 21st May, 2020
Figure 121: Cumulative number of people underwent polymerase chain reaction (PCR) tests for coronavirus (COVID-19) in Japan as of May 22, 2020, by type of patients
Figure 122: India COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 123: India COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 124: India COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 125: India COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 126: India Population Projection (in Million), 2020-2035
Figure 127: India COVID-19 Data, Last Updated to 21st May, 2020
Figure 128: South Korea COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 129: South Korea COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 130: South Korea COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 131: South Korea COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 132: South Korea Population Projection (in Million), 2020-2035
Figure 133: South Korea COVID-19 Data, Last Updated to 21st May, 2020
Figure 134: Singapore COVID-19 Diagnostic Testing Market Size, by Value, 2020-2025 (USD Million)
Figure 135: Singapore COVID-19 Diagnostic Testing Market Size, by COVID-19 Tests, 2020-2025 (in Thousand)
Figure 136: Singapore COVID-19 Diagnostic Testing Market (by Test Type), by Value (USD Million), 2020-2025
Figure 137: Singapore COVID-19 Diagnostic Testing Market (by End-User), by Value (USD Million), 2020-2025
Figure 138: Singapore Population Projection (in Million), 2020-2035
Figure 139: Singapore COVID-19 Data, Last Updated to 21st May, 2020
Figure 140: Biomerieux Annual Revenue (USD Million), Year 2014-2019
Figure 141: Biomerieux Net Income/Loss (USD Million), Year 2014-2019
Figure 142: Biomerieux Sales Revenue Split, by Application Segment (%), FY2019
Figure 143: Biomerieux Sales Revenue Split, by Geography (%), FY2019
Figure 144: Biomerieux R&D Expenses (USD Million), Year 2014-2018
Figure 145: Roche Holding AG Annual Revenue (USD Million), Year 2015-2019
Figure 146: Roche Holding AG Net Income/Loss (USD Million), Year 2015-2019
Figure 147: Roche Holding AG Sales Revenue Split, by Business Segment (%), FY2019
Figure 148: Roche Holding AG R&D Expenses (USD Million), Year 2015-2019
Figure 149: Siemens Healthineers Annual Revenue (USD Million), Year 2015-2019
Figure 150: Siemens Healthineers Net Income/Loss (USD Million), Year 2015-2019
Figure 151: Siemens Healthineers Sales Revenue Split, by Business Segment (%), FY2019
Figure 152: Siemens Healthineers Sales Revenue Split, by Geography (%), FY2019
Figure 153: Abbott Laboratories Annual Revenue (USD Million), Year 2015-2019
Figure 154: Abbott Laboratories Net Income/Loss (USD Million), Year 2015-2019
Figure 155: Abbott Laboratories Sales Revenue Split, by Business Segment (%), FY2019
Figure 156: Abbott Laboratories Sales Revenue Split, by Geography (%), FY2019
Figure 157: Becton Dickinson Annual Revenue (USD Million), Year 2015-2019
Figure 158: Becton Dickinson Net Income/Loss (USD Million), Year 2015-2019
Figure 159: Becton Dickinson Sales Revenue Split, by Business Segment (%), FY2019
Figure 160: Becton Dickinson Sales Revenue Split, by Geography (%), FY2019
Figure 161: Thermo Fisher Scientific Annual Revenue (USD Million), Year 2015-2019
Figure 162: Thermo Fisher Scientific Net Income/Loss (USD Million), Year 2015-2019
Figure 163: Thermo Fisher Scientific Sales Revenue Split, by Business Segment (%), FY2019
Figure 164: Thermo Fisher Scientific Sales Revenue Split, by Geography (%), FY2019
Figure 165: Thermo Fisher Scientific Sales Revenue Split, by Market (%), FY2019
Figure 166: Thermo Fisher Scientific Sales Revenue Split, by Product (%), FY2019
Figure 167: Cepheid Annual Revenue (USD Million), Year 2015-2019
Figure 168: Cepheid Net Income/Loss (USD Million), Year 2015-2019
Figure 169: Cepheid Sales Revenue Split, by Business Segment (%), FY2019
Figure 170: Cepheid Sales Revenue Split, by Geography (%), FY2019
Figure 171: BGI Genomics Annual Revenue (USD Million), Year 2015-2019
Figure 172: BGI Genomics Net Income/Loss (USD Million), Year 2015-2019
Figure 173: Seegene Annual Revenue (USD Million), Year 2015-2019
Figure 174: Seegene Net Income/Loss (USD Million), Year 2015-2019
Figure 175: PerkinElmer Annual Revenue (USD Million), Year 2015-2019
Figure 176: PerkinElmer Net Income/Loss (USD Million), Year 2015-2019
Figure 177: PerkinElmer Sales Revenue Split, by Business Segment (%), FY2019
Figure 178: PerkinElmer Sales Revenue Split, by Geography (%), FY2019

List of Tables

Table A: Main manufacturers of COVID-19 PCR test kits, and estimates of their production capacities
Table B: Main manufacturers of COVID-19 test kits, and estimates of their production capacities (Continued)
Table C: Main manufacturers of COVID-19 test kits, and estimates of their production capacities (Continued)
Table D: Main manufacturers of COVID-19 test kits, and estimates of their production capacities (Continued)
Table E: Theoretical throughputs on the automated PCR machines from the key players
Table F: Theoretical throughputs on the automated PCR machines from the key players (Continued)
Table G: WHO COVID-19 Reference Laboratory Network (Updated on 19th April,2020)
Table H: WHO COVID-19 Reference Laboratory Network (Updated on 19th April,2020) (Continued)
Table I: Some of the Test kit Manufacturers and Commercial Laboratories
Table J: Comparison of Case fatality Ratios for SARS, COVID-19 and seasonal influenza
Table K: Test run as a percentage of population for certain countries
Table L: Few Major Players in Americas COVID-19 Diagnostic Testing Market
Table M: Theoretical throughputs on the automated PCR machines from the key players
Table N: Theoretical throughputs on the automated PCR machines from the key players (Continued)
Table O: COVID-19 Testing Device Applications Authorized by Health Canada
Table P: COVID-19 Testing Device Applications Authorized by Health Canada (Continued)
Table Q: COVID-19 Testing Device Applications Authorized by Health Canada (Continued)
Table R: Few Major Players in Europe COVID-19 Diagnostic Testing Market
Table S: Breakdown of Testing by 3 of the testing strategy pillars
Table T: Pillar 2 breakdown of test types
Table U: COVID-19 Italy Situation Report as of 24th May, 2020, by Region
Table V: Few Major Players in Asia Pacific COVID-19 Diagnostic Testing Market
Table W: Overview of the leading vaccine candidates (Continued)
Table X: Overview of the leading vaccine candidates

Note: Product cover images may vary from those shown

LOADING...

Biomerieux
Roche Holding AG
Siemens Healthineers
Abbott Laboratories
Becton Dickinson
Thermo Fisher Scientific
Cepheid
BGI Genomics
Seegene
PerkinElmer

Note: Product cover images may vary from those shown

LOADING...

FEATURED COMPANIES

FEATURED COMPANIES

RELATED TAGS

RELATED PRODUCTS

Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider and Geography

Respiratory Disease Testing Market Research Report by Product (Blood Gas Test, Imaging Tests, and Respiratory Measurement), End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

Pneumococcal Testing Market Research Report by Method, Technology, Product Type, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Clinical Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Global Non-Invasive Prenatal Testing (NIPT) Market, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis